Anti-HGFR / c-Met Reference Antibody (emibetuzumab)

Product Code: 140140

Molecular Weight:	Molecular Formula:
EC Number:	MDL Number:
Melting Point:	Boiling Point:
Density:	Storage Condition:	-20℃

Product Description: Used in targeted cancer therapy, particularly for tumors with c-Met receptor overexpression or dysregulation. It blocks hepatocyte growth factor (HGF) binding and inhibits c-Met signaling, which is involved in tumor growth, survival, and metastasis. Investigated in clinical trials for non-small cell lung cancer, gastric cancer, and other solid tumors. Enables precise targeting of cancer cells while sparing normal tissues, supporting development of personalized treatment strategies. Also serves as a reference standard in immunoassay development and antibody drug characterization.

Sizes / Availability / Pricing:

Size	Availability	Price	Quantity
	10-20 days	Ft52,045.91	+ -

Anti-HGFR / c-Met Reference Antibody (emibetuzumab)

Used in targeted cancer therapy, particularly for tumors with c-Met receptor overexpression or dysregulation. It blocks hepatocyte growth factor (HGF) binding and inhibits c-Met signaling, which is involved in tumor growth, survival, and metastasis. Investigated in clinical trials for non-small cell lung cancer, gastric cancer, and other solid tumors. Enables precise targeting of cancer cells while sparing normal tissues, supporting development of personalized treatment strategies. Also serves as a reference standard in immunoassay development and antibody drug characterization.

Mechanism	-
Appearance	-
Longevity	-
Strength	-
Storage	-
Shelf Life	-
Allergen(s)	-
Dosage (Range)	-
Recommended Dosage	-
Dosage (Per Day)	-
Recommended Dosage (Per Day)	-
Mix Method	-
Heat Resistance	-
Stable in pH range	-
Solubility	-
Product Types	-
INCI	-

Anti-HGFR / c-Met Reference Antibody (emibetuzumab)

Purchase History for

Cart